Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARK CHRISTOPHER ROQUE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1467802892
CMS profile
10445441
Location
DADE CITY, FL

General Payments · PY2021–2024

$2,817.28

  • Reported across 160 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$717.20

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $717.20 39

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $226.60 12
PFIZER INC. $121.02 6
ABBVIE INC. $108.56 6
Amgen Inc. $75.89 5
GlaxoSmithKline, LLC. $55.41 3
Acerta Pharma LLC $50.41 3
Lilly USA, LLC $31.46 2
Boehringer Ingelheim Pharmaceuticals, Inc. $25.97 1
Agios Pharmaceuticals, Inc. $21.88 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $741.66 43
PY2022 $516.62 29
PY2023 $841.80 49
PY2024 $717.20 39

Payment records · PY2024 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.83 01/24/2024 Food and Beverage Undisputed 01/23/2026 1108111770 CMS
ABBVIE INC. $15.79 05/09/2024 Food and Beverage Undisputed 01/23/2026 1108111772 CMS
ABBVIE INC. $17.52 06/01/2024 Food and Beverage Undisputed 01/23/2026 1108111774 CMS
ABBVIE INC. $24.89 06/21/2024 Food and Beverage Undisputed 01/23/2026 1108111776 CMS
ABBVIE INC. $17.66 07/18/2024 Food and Beverage Undisputed 01/23/2026 1108111778 CMS
ABBVIE INC. $14.87 08/29/2024 Food and Beverage Undisputed 01/23/2026 1108111780 CMS
Agios Pharmaceuticals, Inc. $21.88 01/18/2024 Food and Beverage Undisputed 01/23/2026 1149645506 CMS
Amgen Inc. $14.79 01/10/2024 Food and Beverage Undisputed 01/23/2026 1117669765 CMS
Amgen Inc. $14.75 02/22/2024 Food and Beverage Undisputed 01/23/2026 1117669767 CMS
Amgen Inc. $16.18 04/02/2024 Food and Beverage Undisputed 01/23/2026 1117669769 CMS
Amgen Inc. $13.48 07/11/2024 Food and Beverage Undisputed 01/23/2026 1117669771 CMS
Amgen Inc. $16.69 08/15/2024 Food and Beverage Undisputed 01/23/2026 1117669773 CMS
AstraZeneca Pharmaceuticals LP $19.07 01/23/2024 Food and Beverage Undisputed 01/23/2026 1105598059 CMS
AstraZeneca Pharmaceuticals LP $17.19 07/25/2024 Food and Beverage Undisputed 01/23/2026 1104428561 CMS
AstraZeneca Pharmaceuticals LP $14.15 08/08/2024 Food and Beverage Undisputed 01/23/2026 1104257669 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $25.97 06/13/2024 Food and Beverage Undisputed 01/23/2026 1118022628 CMS
GlaxoSmithKline, LLC. $15.06 01/03/2024 Food and Beverage Undisputed 01/23/2026 1116620313 CMS
GlaxoSmithKline, LLC. $17.83 02/09/2024 Food and Beverage Undisputed 01/23/2026 1116365343 CMS
GlaxoSmithKline, LLC. $22.52 04/17/2024 Food and Beverage Undisputed 01/23/2026 1116565160 CMS
Lilly USA, LLC $17.50 04/05/2024 Food and Beverage Undisputed 01/23/2026 1135755775 CMS
Lilly USA, LLC $13.96 04/23/2024 Food and Beverage Undisputed 01/23/2026 1135755777 CMS
Novo Nordisk Inc $14.22 01/10/2024 Food and Beverage Undisputed 01/23/2026 1100229836 CMS
Novo Nordisk Inc $22.75 02/01/2024 Food and Beverage Undisputed 01/23/2026 1100306829 CMS
Novo Nordisk Inc $24.07 02/13/2024 Food and Beverage Undisputed 01/23/2026 1100366043 CMS
Novo Nordisk Inc $21.28 02/27/2024 Food and Beverage Undisputed 01/23/2026 1100399346 CMS
Novo Nordisk Inc $19.72 03/06/2024 Food and Beverage Undisputed 01/23/2026 1100514043 CMS
Novo Nordisk Inc $19.35 05/09/2024 Food and Beverage Undisputed 01/23/2026 1100255048 CMS
Novo Nordisk Inc $17.16 05/30/2024 Food and Beverage Undisputed 01/23/2026 1100266492 CMS
Novo Nordisk Inc $17.04 06/28/2024 Food and Beverage Undisputed 01/23/2026 1100452306 CMS
Novo Nordisk Inc $14.02 08/14/2024 Food and Beverage Undisputed 01/23/2026 1100557147 CMS
Novo Nordisk Inc $23.60 08/22/2024 Food and Beverage Undisputed 01/23/2026 1100372764 CMS
Novo Nordisk Inc $19.85 09/05/2024 Food and Beverage Undisputed 01/23/2026 1100595361 CMS
Novo Nordisk Inc $13.54 10/15/2024 Food and Beverage Undisputed 01/23/2026 1100241061 CMS
PFIZER INC. $24.48 01/26/2024 Food and Beverage Undisputed 01/23/2026 1130969386 CMS
PFIZER INC. $19.85 03/01/2024 Food and Beverage Undisputed 01/23/2026 1131122831 CMS
PFIZER INC. $20.89 04/11/2024 Food and Beverage Undisputed 01/23/2026 1131382317 CMS
PFIZER INC. $20.74 06/06/2024 Food and Beverage Undisputed 01/23/2026 1131655000 CMS
PFIZER INC. $16.79 08/20/2024 Food and Beverage Undisputed 01/23/2026 1131841254 CMS
PFIZER INC. $18.27 09/19/2024 Food and Beverage Undisputed 01/23/2026 1132029125 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.